Published in Life Sci on May 30, 2013
Inflammatory cytokine-associated depression. Brain Res (2014) 0.84
Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? J Neural Transm (Vienna) (2014) 0.82
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters. Pharmacol Rev (2016) 0.78
Intestinal Serotonin Transporter Inhibition by Toll-Like Receptor 2 Activation. A Feedback Modulation. PLoS One (2016) 0.75
Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol (2003) 1.79
The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J (2005) 1.07
Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology (2005) 1.02
Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology (2005) 1.01
Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood (2002) 1.00
Different susceptibility to social defeat stress of BalbC and C57BL6/J mice. Behav Brain Res (2010) 0.97
5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood (2002) 0.96
Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders. Prog Brain Res (2008) 0.93
Identification and importance of N-glycosylation of the human 5-hydroxytryptamine3A receptor subunit. Biochem Pharmacol (2004) 0.92
Circadian profile of peripheral hormone levels in Sprague-Dawley rats and in common marmosets (Callithrix jacchus). In Vivo (2010) 0.90
Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One (2010) 0.90
Dopamine targets cycling B cells independent of receptors/transporter for oxidative attack: Implications for non-Hodgkin's lymphoma. Proc Natl Acad Sci U S A (2006) 0.90
Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. Pharmacol Biochem Behav (2010) 0.89
Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: a time-course study in the rat. Physiol Behav (2007) 0.89
SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies. Leuk Res (2010) 0.88
Identification of 5-HT3A and 5-HT3B receptor subunits in human hippocampus. Neuropharmacology (2007) 0.87
Alterations of behavioral and endocrinological reactivity induced by 3 brief social defeats in rats: relevance to human psychopathology. Psychoneuroendocrinology (2009) 0.84
Importance of the C-terminus of the human 5-HT3A receptor subunit. Neuropharmacology (2008) 0.83
Single exposure to social defeat increases corticotropin-releasing factor and glucocorticoid receptor mRNA expression in rat hippocampus. Brain Res (2005) 0.83
Characterisation of the endogenous human peripheral serotonin transporter SLC6A4 reveals surface expression without N-glycosylation. J Neuroimmunol (2008) 0.81
Evidence for functional trace amine associated receptor-1 in normal and malignant B cells. Leuk Res (2011) 0.81
Proteomic analysis of rat cortical neurons after fluoxetine treatment. Brain Res (2006) 0.80
The identification of N-glycosylated residues of the human 5-HT3B receptor subunit: importance for cell membrane expression. J Neurochem (2011) 0.80
Lymphoma cells protected from apoptosis by dysregulated bcl-2 continue to bind annexin V in response to B-cell receptor engagement: a cautionary tale. Leuk Res (2005) 0.80
Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression. Eur Neuropsychopharmacol (2010) 0.80
Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist. Psychopharmacology (Berl) (2010) 0.79
Conditioning properties of social subordination in rats: behavioral and biochemical correlates of anxiety. Horm Behav (2006) 0.79
Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background. Int J Neuropsychopharmacol (2010) 0.78
Identification and functional significance of N-glycosylation of the 5-ht5A receptor. Neurochem Int (2007) 0.78
Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge. Int J Neuropsychopharmacol (2010) 0.77
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome. Bioorg Med Chem Lett (2010) 0.77
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.77
5-HT: the promiscuous and happy hormone! Curr Opin Pharmacol (2011) 0.77
Effect of the p38 MAPK inhibitor SB-239063 on Lipopolysaccharide-induced psychomotor retardation and peripheral biomarker alterations in rats. Eur J Pharmacol (2011) 0.77
5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor. Br J Pharmacol (2013) 0.76
Quantitative analysis of two-dimensional gel-separated proteins using isotopically marked alkylating agents and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom (2002) 0.76
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue. Eur J Pharmacol (2006) 0.76
Proteomics of rat hypothalamus, hippocampus and pre-frontal/frontal cortex after central administration of the neuropeptide PACAP. Mol Biol Rep (2011) 0.75
Detection of mRNA encoding receptors by in situ and Northern hybridization. Methods Mol Biol (2012) 0.75
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death. Invest New Drugs (2011) 0.75
Serum proteomic analysis during nicotine self-administration, extinction and relapse in rats. Electrophoresis (2008) 0.75
Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration. Proteomics (2005) 0.75
mRNA: detection by in situ and northern hybridization. Methods Mol Biol (2005) 0.75